Business article - March 2, 2015
SEC: Keep up With Compliance, Disclosures
Shoring up compliance and disclosure procedures is the best way for pharmaceutical companies to avoid brushes with regulatory agencies, according to the U.S. Securities and Exchange Commission (SEC). Andrew Ceresney, the SEC’s top enforcement director, delivered the message to attendees at the recent Annual Pharmaceutical Compliance Congress. Companies need to accurately report their dealings with […]
